Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does AMLODIPINE Cause Troponin increased? 156 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 156 reports of Troponin increased have been filed in association with AMLODIPINE (Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide). This represents 0.2% of all adverse event reports for AMLODIPINE.

156
Reports of Troponin increased with AMLODIPINE
0.2%
of all AMLODIPINE reports
47
Deaths
148
Hospitalizations

How Dangerous Is Troponin increased From AMLODIPINE?

Of the 156 reports, 47 (30.1%) resulted in death, 148 (94.9%) required hospitalization, and 51 (32.7%) were considered life-threatening.

Is Troponin increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for AMLODIPINE. However, 156 reports have been filed with the FAERS database.

What Other Side Effects Does AMLODIPINE Cause?

Hypotension (6,504) Toxicity to various agents (5,554) Completed suicide (5,267) Drug ineffective (4,091) Dyspnoea (3,907) Dizziness (3,536) Intentional overdose (3,427) Fall (3,215) Fatigue (3,141) Headache (2,907)

What Other Drugs Cause Troponin increased?

CLOZAPINE (810) PEMBROLIZUMAB (269) QUETIAPINE (200) ATORVASTATIN (176) DOXORUBICIN (162) ACETAMINOPHEN (151) ASPIRIN (151) FUROSEMIDE (143) NIVOLUMAB (141) CARBOPLATIN (133)

Which AMLODIPINE Alternatives Have Lower Troponin increased Risk?

AMLODIPINE vs AMLODIPINE BESILATE AMLODIPINE vs AMLODIPINE\ATORVASTATIN AMLODIPINE vs AMLODIPINE\BENAZEPRIL AMLODIPINE vs AMLODIPINE\HYDROCHLOROTHIAZIDE\OLMESARTAN AMLODIPINE vs AMLODIPINE\HYDROCHLOROTHIAZIDE\OLMESARTAN MEDOXOMIL

Related Pages

AMLODIPINE Full Profile All Troponin increased Reports All Drugs Causing Troponin increased AMLODIPINE Demographics